7. Zelnorm - Top 10 Warnings and Recalls

Drug: Zelnorm

2006 sales: $561 million

Manufacturer: Novartis

Safety concern: Recall; heart risks

Related Articles:
> FDA allows limited Zelnorm use. Report
> Novartis shares slide after Zelnorm gets yanked. Report
> EMEA committee rejects Novartis' Zelnorm. Report

7. Zelnorm - Top 10 Warnings and Recalls
Read more on

Suggested Articles

The FDA wants to know what, exactly, is in a drug name—and whether it influences how the product is perceived. So it's launching a study to find out.

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.